Cargando…
Selection of HIV-1 for resistance to fifth-generation protease inhibitors reveals two independent pathways to high-level resistance
Darunavir (DRV) is exceptional among potent HIV-1 protease inhibitors (PIs) in high drug concentrations that are achieved in vivo. Little is known about the de novo resistance pathway for DRV. We selected for resistance to high drug concentrations against 10 PIs and their structural precursor DRV. M...
Autores principales: | Spielvogel, Ean, Lee, Sook-Kyung, Zhou, Shuntai, Lockbaum, Gordon J, Henes, Mina, Sondgeroth, Amy, Kosovrasti, Klajdi, Nalivaika, Ellen A, Ali, Akbar, Yilmaz, Nese Kurt, Schiffer, Celia A, Swanstrom, Ronald |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
eLife Sciences Publications, Ltd
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10065791/ https://www.ncbi.nlm.nih.gov/pubmed/36920025 http://dx.doi.org/10.7554/eLife.80328 |
Ejemplares similares
-
Avoiding Drug Resistance by Substrate Envelope-Guided Design: Toward Potent and Robust HCV NS3/4A Protease Inhibitors
por: Matthew, Ashley N., et al.
Publicado: (2020) -
Crystal Structure of SARS-CoV-2 Main Protease in Complex with the Non-Covalent Inhibitor ML188
por: Lockbaum, Gordon J., et al.
Publicado: (2021) -
Drug Resistance
Conferred by Mutations Outside the
Active Site through Alterations in the Dynamic and Structural Ensemble
of HIV-1 Protease
por: Ragland, Debra A., et al.
Publicado: (2014) -
Viral Protease Inhibitors
por: Anderson, Jeffrey, et al.
Publicado: (2009) -
N-glycosylation in the protease domain of trypsin-like serine proteases mediates calnexin-assisted protein folding
por: Wang, Hao, et al.
Publicado: (2018)